Sertraline-Associated Multiple Acyl-CoA Dehydrogenase Deficiency: An Emerging, Treatable Cause of Myopathy
Open Access
- 9 November 2026
- journal article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- p. 1-3
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Acquired Multiple Acyl‐Coenzyme A Dehydrogenase Deficiency Associated With Sertraline in Sweden—A Nationwide Population‐Based StudyEuropean Journal of Neurology, 2026
- Exposure to sertraline and ranolazine is common among adult patients with genetically uncharacterized lipid storage myopathyJournal of the Neurological Sciences, 2025
- Lipid storage myopathy associated with sertraline treatment is an acquired mitochondrial disorder with respiratory chain deficiencyActa Neuropathologica, 2024
- Multiple Acyl‐Coenzyme A Dehydrogenase Deficiency Is Associated with Sertraline Use – Is There an Acquired Form?Annals of Neurology, 2024
- Lipid MyopathiesJournal of Clinical Medicine, 2018
- Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiencyOrphanet Journal of Rare Diseases, 2014
- Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of GlucolipotoxicityObesity, 2010